This inventor holds 1 USPTO granted patent. Top assignee: Csl Behring Gmbh. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Thomas Renné: Innovator in Thrombus Prevention
Introduction
Thomas Renné is a notable inventor based in Wuerzburg, Germany. He has made significant contributions to the field of medicine, particularly in the area of thrombus prevention. His innovative work focuses on the use of inhibitors to target factor XII, which plays a crucial role in blood clotting.
Latest Patents
Renné holds a patent titled "Prevention of thrombus formation and/or stabilization with inhibitors of factor XII or activated factor XII." This invention relates to the use of at least one antibody and/or one inhibitor for inhibiting factor XII, thereby preventing the formation and stabilization of three-dimensional thrombi. The patent also discusses a pharmaceutical formulation and the potential of factor XII as an anti-thrombotic target. He has 1 patent to his name.
Career Highlights
Thomas Renné is associated with Csl Behring GmbH, a company known for its focus on biopharmaceuticals. His work at the company has allowed him to explore innovative solutions in the medical field, particularly in thrombosis management.
Collaborations
Renné collaborates with Bernhard Nieswandt, a fellow researcher in the field. Their partnership has contributed to advancements in understanding thrombus formation and prevention.
Conclusion
Thomas Renné's contributions to thrombus prevention through his innovative patent highlight his role as a key inventor in the medical field. His work continues to pave the way for new therapeutic approaches in managing blood clotting disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile